• Cefiderocol vs. Ceftolozane: In Vitro Susceptibility in Resi

  2026-04-20

  This study presents a large-scale, multi-country analysis of cefiderocol’s in vitro efficacy against European Enterobacterales, including isolates resistant to both meropenem and β-lactam/β-lactamase inhibitor combinations. The findings highlight cefiderocol’s superior or comparable activity to available alternatives, providing critical guidance for researchers and clinicians facing multidrug-resistant Gram-negative infections.

• Distinct Roles of GluN2A and GluN2B in TMJ Inflammatory Pain

  2026-04-19

  This study uncovers how NMDAR subunits GluN2A and GluN2B regulate gap junction and pannexin expression in trigeminal ganglia during TMJ inflammation, shaping peripheral sensitization underlying orofacial allodynia. The findings clarify intracellular signaling pathways involved, offering new mechanistic targets for pain modulation in TMJ disorders.

• Platanoside Inhibits Ferroptosis in ALI via Keap1/Nrf2/GPX4

  2026-04-18

  This study demonstrates that platanoside protects against acute lung injury (ALI) by promoting autophagy-dependent Keap1 degradation, which activates the Nrf2/GPX4 antioxidant pathway and inhibits ferroptosis. These mechanistic insights highlight a promising therapeutic approach targeting redox and inflammatory pathways in ALI.

• NPT1-Mediated Renal Secretion of Faropenem: Transport Mechan

  2026-04-17

  This study provides the first molecular evidence that human NPT1, an inorganic phosphate transporter in the renal apical membrane, mediates the transport of p-aminohippuric acid (PAH) and several organic anions including faropenem. The findings clarify substrate specificity, kinetic parameters, and mechanistic underpinnings of renal drug secretion, with direct implications for optimizing drug design and pharmacokinetic research.

• Amyloid Beta-peptide (25-35): Empowering Alzheimer's Disease

  2026-04-16

  Amyloid Beta-peptide (25-35) (Aβ25-35) offers a robust, reproducible neurotoxicity platform for dissecting Alzheimer's pathology and screening neuroprotective interventions. Its use in microglial polarization and amyloid aggregation studies bridges mechanistic insight with translational workflows, giving researchers a validated edge in neurodegenerative disease research.

• MG-132: Bridging Proteasome Inhibition to Translational Immu

  2026-04-15

  This thought-leadership piece explores the mechanistic underpinnings and translational potential of MG-132, a peptide aldehyde proteasome inhibitor, in the context of apoptosis assays, oxidative stress, and viral immunology. Integrating recent discoveries on REC8's role in antiviral innate immunity, the article delivers actionable guidance for researchers seeking to translate cellular insights into robust experimental models. Key numeric claims are evidence-labeled, and best practice protocol parameters are included for experimental rigor.

• Brassinolide as an Apoptosis Inducer and Plant Growth Regula

  2026-04-14

  Brassinolide from APExBIO enables robust, cross-domain research—from precise apoptosis assays in prostate cancer models to quantitative plant growth bioassays. This guide details optimized protocols, troubleshooting insights, and unique workflow enhancements grounded in peer-reviewed evidence.

• Ceruletide (Caerulein): Mechanistic Insights and Assay Preci

  2026-04-13

  Discover how Ceruletide, a synthetic decapeptide, enables mechanistic and quantitative advances in pancreatic fibrosis and gastrointestinal physiology studies. This article uniquely bridges molecular pharmacology with cutting-edge cell signaling insights, offering actionable guidance for assay optimization.

• Chlorpromazine HCl in Dopamine Receptor Antagonist Workflows

  2026-04-12

  Chlorpromazine HCl, a gold-standard dopamine receptor antagonist, empowers researchers to dissect endocytic mechanisms and neurotransmitter pathways across neuroscience and infection biology. This article offers advanced protocol insights, cross-validates performance with peer-reviewed studies, and delivers troubleshooting guidance for reliable, reproducible results.

• Targeting Pancreatic Fibrosis via MFGE8-ANXA1-SMAD2/3 Modula

  2026-04-12

  This study introduces a multimodal approach using umbilical cord-derived mesenchymal stem cells (UCMSCs), their extracellular vesicles (EVs), and engineered rhMFGE8 nanoparticles to mitigate pancreatic fibrosis in chronic pancreatitis. By elucidating the MFGE8-dependent modulation of the ANXA1-SMAD2/3 signaling axis in pancreatic stellate cells, the paper advances the mechanistic understanding and therapeutic potential for fibrotic pancreatic disease.

• SR 11302: Advanced AP-1 Transcription Factor Inhibitor Workf

  2026-04-11

  SR 11302, a selective AP-1 transcription factor inhibitor from APExBIO, delivers unparalleled control over AP-1-driven pathways in cancer models. This article translates fresh reference and workflow evidence into actionable protocols, troubleshooting tactics, and comparative insights for chemoprevention and targeted therapy research.

• Sodium Picosulfate in Advanced Constipation Research Workflo

  2026-04-11

  Sodium Picosulfate, as supplied by APExBIO, is a versatile tool for studying electrolyte dynamics and bowel motility in translational and preclinical models. This article details optimized experimental workflows, troubleshooting strategies, and cross-references the latest research, highlighting practical innovations for chronic and opioid-induced constipation studies.

• A40926: Glycopeptide Antibiotic and Dalbavancin Precursor...

  2026-04-10

  A40926 is a natural glycopeptide antibiotic and direct precursor to dalbavancin, exhibiting potent bactericidal activity against Gram-positive bacteria and Neisseria gonorrhoeae. Its mechanism—binding the D-alanyl-D-alanine terminus of peptidoglycan precursors—enables robust inhibition of cell wall synthesis, making it pivotal in MRSA and multidrug-resistant bacterial research.

• A40926 (SKU BA1486): Scenario-Driven Optimization for Rel...

  2026-04-09

  This article delivers evidence-based, scenario-driven strategies for deploying A40926 (SKU BA1486) in cell viability and antibacterial assays targeting Gram-positive bacteria and Neisseria gonorrhoeae. Drawing on real laboratory challenges, quantitative data, and validated workflows, it demonstrates how A40926 ensures reproducibility, sensitivity, and robust data for biomedical researchers. Vendor reliability and best practices are discussed to empower informed selection and experimental design.

• A40926: Mechanistic Insights and Next-Gen Strategies for ...

  2026-04-08

  Unlock the scientific intricacies of A40926, a potent glycopeptide antibiotic and dalbavancin precursor, with an expert analysis of its mechanism, biosynthetic regulation, and strategic applications in multidrug-resistant infection research. This article offers a unique, mechanistic perspective and advanced experimental guidance for researchers tackling Gram-positive and Neisseria gonorrhoeae pathogens.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page